Monopar Therapeutics (NASDAQ:MNPR) filed to sell 882,761 shares of common stock for holders. This prospectus is not an offer to sell. Filing More on Monopar Therapeutics Monopar: Radiopharmaceutical ...
Blaize (BZAI) and BurTech Acquisition Corp announced that they expect to complete their previously announced business combination on January 12. The combined company will be named ...
Preferred stock is often described as a stock that acts like a bond. Investors value them for their steady income, not the potential market price increases.
Some results have been hidden because they may be inaccessible to you